Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle

Nucleic Acids Research

Volumn 38, Issue 13, 2010, Pages 4296-4312

  Raichur, S ^a,b   Fitzsimmons, R L ^a   Myers, S A ^a   Pearen, M A ^a   Lau, P ^a   Eriksson, N ^a   Wang, S M ^a   Muscat, G E O ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Eli Lilly Singapore Pte Ltd   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ADENYLATE KINASE; AMINE OXIDASE (FLAVIN CONTAINING); APOLIPOPROTEIN C1; CCAAT BINDING FACTOR; CYTOCHROME C OXIDASE; DESMIN; EPENDYMIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FATTY ACID SYNTHASE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HAPTOGLOBIN; HISTONE DEACETYLASE 4; IMMUNOGLOBULIN HEAVY CHAIN; LIVER X RECEPTOR; MANNOSE 6 PHOSPHATE; MELANOMA ANTIGEN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; PROTEIN KINASE C THETA; PROTEIN SWI; RAB11 PROTEIN; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR ALPHA 1; SPERMINE SYNTHASE; STEAROYL COENZYME A; TRANSKETOLASE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; DOWN REGULATION; FATTY ACID OXIDATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HYPERGLYCEMIA; LIGAND BINDING; LIPID METABOLISM; METABOLIC DISORDER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STATISTICAL ANALYSIS; TRANSGENIC MOUSE; UNINDEXED SEQUENCE; UPREGULATION;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; CELL LINE; FATTY ACIDS; GENE EXPRESSION PROFILING; GLUCOSE INTOLERANCE; HUMANS; INSULIN; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; ORPHAN NUCLEAR RECEPTORS; PROTO-ONCOGENE PROTEINS C-AKT; SEQUENCE DELETION; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANS-ACTIVATORS;

ANIMALIA; MUS MUSCULUS;

EID: 77955258637     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq180     Document Type: Article

References (57)

1. Raspe,E., Duez,H., Gervois,P., Fievet,C., Fruchart,J.C., Besnard,S., Mariani,J., Tedgui,A. and Staels,B. (2001) Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J. Biol. Chem., 276, 2865-2871.
2. Mamontova,A., Seguret-Mace,S., Esposito,B., Chaniale,C., Bouly,M., Delhaye-Bouchaud,N., Luc,G., Staels,B., Duverger,N., Mariani,J. et al. (1998) Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation, 98, 2738-2743.
3. Lau,P., Nixon,S.J., Parton,R.G. and Muscat,G.E. (2004) RORalpha regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells: caveolin-3 and CPT-1 are direct targets of ROR. J. Biol. Chem., 279, 36828-36840.
4. Raichur,S., Lau,P., Staels,B. and Muscat,G.E. (2007) Retinoid-related orphan receptor gamma regulates several genes that control metabolism in skeletal muscle cells: links to modulation of reactive oxygen species production. J. Mol. Endocrinol., 39, 29-44.
5. Vu-Dac,N., Gervois,P., Grotzinger,T., De Vos,P., Schoonjans,K., Fruchart,J.C., Auwerx,J., Mariani,J., Tedgui,A. and Staels,B. (1997) Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha. J Biol. Chem., 272, 22401-22404.
6. Jetten,A.M. (2009) Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl. Recept. Signal, 7, e003.
7. Kang,H.S., Angers,M., Beak,J.Y., Wu,X., Gimble,J.M., Wada,T., Xie,W., Collins,J.B., Grissom,S.F. and Jetten,A.M. (2007) Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol. Genomics, 31, 281-294.
8. Lau,P., Fitzsimmons,R.L., Raichur,S., Wang,S.C., Lechtken,A. and Muscat,G.E. (2008) The orphan nuclear receptor, ROR{alpha}, regulates gene expression that controls lipid metabolism: STAGGERER (SG/SG) mice are resistant to diet-induced obesity. J. Biol. Chem., 283, 18411-18421.
9. Schmitz-Peiffer,C. (2000) Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal, 12, 583-594.
10. Brennan,K.J. and Hardeman,E.C. (1993) Quantitative analysis of the human alpha-skeletal actin gene in transgenic mice. J. Biol. Chem., 268, 719-725.
11. Muscat,G.E. and Kedes,L. (1987) Multiple 5'-flanking regions of the human alpha-skeletal actin gene synergistically modulate muscle-specific expression. Mol. Cell Biol., 7, 4089-4099.
12. Wang,Y.X., Zhang,C.L., Yu,R.T., Cho,H.K., Nelson,M.C., Bayuga-Ocampo,C.R., Ham,J., Kang,H. and Evans,R.M. (2004) Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol., 2, e294.
13. Jaenisch, R. (1988) Transgenic animals. Science, 240, 1468-1474.
14. Mitrecic,D., Huzak,M., Curlin,M. and Gajovic,S. (2005) An improved method for determination of gene copy numbers in transgenic mice by serial dilution curves obtained by real-time quantitative PCR assay. J. Biochem. Biophys. Methods, 64, 83-98.
15. Bookout,A.L., Jeong,Y., Downes,M., Yu,R.T., Evans,R.M. and Mangelsdorf,D.J. (2006) Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell, 126, 789-799.
16. Yang,X., Downes,M., Yu,R.T., Bookout,A.L., He,W., Straume,M., Mangelsdorf,D.J. and Evans,R.M. (2006) Nuclear receptor expression links the circadian clock to metabolism. Cell, 126, 801-810.
17. Myers,S.A., Eriksson,N., Burow,R., Wang,S.C. and Muscat,G.E. (2009) Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues. Mol. Cell Endocrinol., 309, 101-108.
18. Brozinick,J.T. Jr and Birnbaum,M.J. (1998) Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. J. Biol. Chem., 273, 14679-14682.
19. Watt,M.J., Dzamko,N., Thomas,W.G., Rose-John,S., Ernst,M., Carling,D., Kemp,B.E., Febbraio,M.A. and Steinberg,G.R. (2006) CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat. Med., 12, 541-548.
20. Pearen,M.A., Myers,S.A., Raichur,S., Ryall,J.G., Lynch,G.S. and Muscat,G.E. (2008) The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology, 149, 2853-2865.
21. McBroom,L.D., Flock,G. and Giguere,V. (1995) The nonconserved hinge region and distinct amino-terminal domains of the ROR alpha orphan nuclear receptor isoforms are required for proper DNA bending and ROR alpha-DNA interactions. Mol. Cell Biol., 15, 796-808.
22. Hamilton,B.A., Frankel,W.N., Kerrebrock,A.W., Hawkins,T.L., FitzHugh,W., Kusumi,K., Russell,L.B., Mueller,K.L., van Berkel,V., Birren,B.W. et al. (1996) Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature, 379, 736-739.
23. Clapham,J.C., Arch,J.R., Chapman,H., Haynes,A., Lister,C., Moore,G.B., Piercy,V., Carter,S.A., Lehner,I., Smith,S.A. et al. (2000) Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature, 406, 415-418.
24. Genoux,A., Dehondt,H., Helleboid-Chapman,A., Duhem,C., Hum,D.W., Martin,G., Pennacchio,L.A., Staels,B., Fruchart-Najib,J. and Fruchart,J.C. (2005) Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha. Arterioscler. Thromb. Vasc. Biol., 25, 1186-1192.
25. Lind,U., Nilsson,T., McPheat,J., Stromstedt,P.E., Bamberg,K., Balendran,C. and Kang,D. (2005) Identification of the human ApoAV gene as a novel RORalpha target gene. Biochem. Biophys. Res. Commun., 330, 233-241.
26. Giguere,V., Tini,M., Flock,G., Ong,E., Evans,R.M. and Otulakowski,G. (1994) Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev., 8, 538-553.
27. Kovacic,S., Soltys,C.L., Barr,A.J., Shiojima,I., Walsh,K. and Dyck,J.R. (2003) Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J. Biol. Chem., 278, 39422-39427.
28. Hahn-Windgassen,A., Nogueira,V., Chen,C.C., Skeen,J.E., Sonenberg,N. and Hay,N. (2005) Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem., 280, 32081-32089.
29. Kola,B., Boscaro,M., Rutter,G.A., Grossman,A.B. and Korbonits,M. (2006) Expanding role of AMPK in endocrinology. Trends Endocrinol. Metab., 17, 205-215.
30. Osler,M.E. and Zierath,J.R. (2008) Adenosine 5'-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology, 149, 935-941.
31. Wada,T., Kang,H.S., Jetten,A.M. and Xie,W. (2008) The emerging role of nuclear receptor ROR{alpha} and its crosstalk with LXR in Xeno- and endobiotic gene regulation. Exp. Biol. Med. (Maywood), 233, 1191-1201.
32. Wada,T., Kang,H.S., Angers,M., Gong,H., Bhatia,S., Khadem,S., Ren,S., Ellis,E., Strom,S.C., Jetten,A.M. et al. (2008) Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3). Mol. Pharmacol., 73, 891-899.
33. Askari,B., Kanter,J.E., Sherrid,A.M., Golej,D.L., Bender,A.T., Liu,J., Hsueh,W.A., Beavo,J.A., Coleman,R.A. and Bornfeldt,K.E. (2007) Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. Diabetes, 56, 1143-1152.
34. Kudo,T., Tamagawa,T., Kawashima,M., Mito,N. and Shibata,S. (2007) Attenuating effect of clock mutation on triglyceride contents in the ICR mouse liver under a high-fat diet. J. Biol. Rhythms, 22, 312-323.
35. Ducharme,N.A. and Bickel,P.E. (2008) Lipid droplets in lipogenesis and lipolysis. Endocrinology, 149, 942-949.
36. Choi,C.S., Savage,D.B., Kulkarni,A., Yu,X.X., Liu,Z.X., Morino,K., Kim,S., Distefano,A., Samuel,V.T., Neschen,S. et al. (2007) Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J. Biol. Chem., 282, 22678-22688.
37. Krishnan,J., Suter,M., Windak,R., Krebs,T., Felley,A., Montessuit,C., Tokarska-Schlattner,M., Aasum,E., Bogdanova,A., Perriard,E. et al. (2009) Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab., 9, 512-524.
38. Cho,H., Mu,J., Kim,J.K., Thorvaldsen,J.L., Chu,Q., Crenshaw,E.B. 3rd, Kaestner,K.H., Bartolomei,M.S., Shulman,G.I. and Birnbaum,M.J. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science, 292, 1728-1731.
39. Garofalo,R.S., Orena,S.J., Rafidi,K., Torchia,A.J., Stock,J.L., Hildebrandt,A.L., Coskran,T., Black,S.C., Brees,D.J., Wicks,J.R. et al. (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest., 112, 197-208.
40. Kumar,A., Harris,T.E., Keller,S.R., Choi,K.M., Magnuson,M.A. and Lawrence,J.C. Jr (2008) Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity. Mol. Cell Biol., 28, 61-70.
41. Gonzalez,E. and McGraw,T.E. (2006) Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane. Mol. Biol. Cell, 17, 4484-4493.
42. Larance,M., Ramm,G. and James,D.E. (2008) The GLUT4 code. Mol. Endocrinol., 22, 226-233.
43. Hegarty,B.D., Turner,N., Cooney,G.J. and Kraegen,E.W. (2009) Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase. Acta. Physiol. (Oxf), 196, 129-145.
44. Viollet,B., Athea,Y., Mounier,R., Guigas,B., Zarrinpashneh,E., Horman,S., Lantier,L., Hebrard,S., Devin-Leclerc,J., Beauloye,C. et al. (2009) AMPK: lessons from transgenic and knockout animals. Front. Biosci., 14, 19-44.
45. Planavila,A., Alegret,M., Sanchez,R.M., Rodriguez-Calvo,R., Laguna,J.C. and Vazquez-Carrera,M. (2005) Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice. Biochem. Pharmacol., 69, 1195-1204.
46. Rutter,G.A., Da Silva Xavier,G. and Leclerc,I. (2003) Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem. J., 375, 1-16.
47. Jorgensen,S.B., Viollet,B., Andreelli,F., Frosig,C., Birk,J.B., Schjerling,P., Vaulont,S., Richter,E.A. and Wojtaszewski,J.F. (2004) Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem., 279, 1070-1079.
48. Jorgensen,S.B., Wojtaszewski,J.F., Viollet,B., Andreelli,F., Birk,J.B., Hellsten,Y., Schjerling,P., Vaulont,S., Neufer,P.D., Richter,E.A. et al. (2005) Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. FASEB J., 19, 1146-1148.
49. Narkar,V.A., Downes,M., Yu,R.T., Embler,E., Wang,Y.X., Banayo,E., Mihaylova,M.M., Nelson,M.C., Zou,Y., Juguilon,H. et al. (2008) AMPK and PPARdelta agonists are exercise mimetics. Cell, 134, 405-415.
50. Musi,N., Fujii,N., Hirshman,M.F., Ekberg,I., Froberg,S., Ljungqvist,O., Thorell,A. and Goodyear,L.J. (2001) AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes, 50, 921-927.
51. Musi,N., Hayashi,T., Fujii,N., Hirshman,M.F., Witters,L.A. and Goodyear,L.J. (2001) AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 280, E677-684.
52. Fujii,N., Aschenbach,W.G., Musi,N., Hirshman,M.F. and Goodyear,L.J. (2004) Regulation of glucose transport by the AMP-activated protein kinase. Proc. Nutr. Soc., 63, 205-210.
53. Wagner,B.L., Valledor,A.F., Shao,G., Daige,C.L., Bischoff,E.D., Petrowski,M., Jepsen,K., Baek,S.H., Heyman,R.A., Rosenfeld,M.G. et al. (2003) Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol. Cell Biol., 23, 5780-5789.
54. Viollet,B., Foretz,M., Guigas,B., Horman,S., Dentin,R., Bertrand,L., Hue,L. and Andreelli,F. (2006) Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J. Physiol., 574, 41-53.
55. Yang,J., Craddock,L., Hong,S. and Liu,Z.M. (2009) AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells. J. Cell Biochem., 106, 414-426.
56. Hardie,D.G., Carling,D. and Carlson,M. (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem., 67, 821-855.
57. Dobrzyn,A., Dobrzyn,P., Lee,S.H., Miyazaki,M., Cohen,P., Asilmaz,E., Hardie,D.G., Friedman,J.M. and Ntambi,J.M. (2005) Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 288, E599-E607.